ロード中...
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells
Background: Heteronemin, a marine sesterterpenoid-type natural product, possesses an antiproliferative effect in cancer cells. In addition, heteronemin has been shown to inhibit p53 expression. Our laboratory has demonstrated that the thyroid hormone deaminated analogue, tetrac, activates p53 and in...
保存先:
| 出版年: | Mar Drugs |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7401260/ https://ncbi.nlm.nih.gov/pubmed/32630719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md18070348 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|